Completed and ongoing trials examining the role of GLP-1R agonists, especially semaglutide, in the treatment of glaucoma, AMD, Alzheimers, and Parkinsons disease, were searched on the public clinical trial registry clinicaltrials.gov ( NCT04777409, NCT04777396, NCT03811561, NCT01843075, NCT04232969, NCT03659682, NCT02953665, NCT04305002, NCT03439943, NCT04269642, NCT04154072, NCT02673931, NCT02829502, NCT02838589, NCT00418288, NCT00256256, NCT03948347, NCT03287076 , NCT02684578, NCT05035095 )
However, the platform prohibits showing or promoting disordered eating or dangerous weight loss behaviors, as well as ads and sponsored posts that are "marketed for weight loss, weight gain, fat reduction, detox, appetite suppressants, or that promote unsafe mental health behaviors." This includes "products that use 'Glucagon-like peptide (GLP), 'GLP-1,' or similar terms in the product title or branding," the company's advertising guidelines state
FDA announced it is considering removing GLP-1 medications from the 503B bulks list
Most patients in our study who had ischemic optic neuropathy were either men or men and women aged 50 to 65, said Dave, an associate professor at the Ernest Mario School of Pharmacy and the lead author of the study
Ultraprocessed foods, which often contain high levels of sugar, salt or both, are especially good at triggering a quick hit of these neurochemicals, which is why they can become so addictive
KB ROSEHIPS Food Supplement comes in 500 mg